Icad Inc Stock Investor Sentiment

ICAD Stock  USD 2.41  0.28  13.15%   
About 55% of Icad's shareholders are presently thinking to get in. The analysis of the overall investor sentiment regarding icad inc suggests that some traders are interested. The current market sentiment, together with Icad's historical and current headlines, can help investors time the market. In addition, many technical investors use icad inc stock news signals to limit their universe of possible portfolio assets.
  

Icad Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Icad can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over a year ago at news.google.com         
Biopharma relieved as High Court upholds abortion pillfor now - FierceBiotech
Google News at Macroaxis
over a year ago at finance.yahoo.com         
iCADs ProFound Insights, ProFound Impact Webinar Series to Feature Boca Raton Regional Hospital
Yahoo News
over a year ago at news.google.com         
BNP PARIBAS EXANE Upgrades ICADE - Nasdaq
Google News at Macroaxis
over a year ago at finance.yahoo.com         
New and Real-World Clinical Evidence Confirms ProFound AI Increases Cancer Detection without Increas...
Yahoo News
over a year ago at news.google.com         
Non-melanoma Skin Cancer Market size to grow at a CAGR of 5.76 ... - PR Newswire
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Insider Buying iCAD, Inc. Insider Purchases 40,000 Shares of Stock
news
over a year ago at thelincolnianonline.com         
Greenwood Capital Associates LLC Has 603,000 Holdings in iCAD, Inc.
news
over a year ago at thelincolnianonline.com         
Oppenheimer Analysts Increase Earnings Estimates for iCAD, Inc.
news
over a year ago at finance.yahoo.com         
Trade Alert The Executive Chair Of iCAD, Inc. , Dana Brown, Has Just Spent US52k Buying A Few More S...
Yahoo News
over a year ago at simplywall.st         
Trade Alert The Executive Chair Of iCAD, Inc. , Dana Brown, Has Just Spent US52k Buying A Few More S...
Simply Wall St News at Macroaxis
over a year ago at news.google.com         
ProFound AI Risk Outperforms Traditional, Widely-Accepted Breast Cancer Risk Models for Both Short-t...
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Inari Medical iCAD Head-To-Head Analysis
news
over a year ago at simplywall.st         
iCAD Full Year 2022 Earnings EPS Beats Expectations
Simply Wall St News at Macroaxis
over a year ago at insidermonkey.com         
iCAD, Inc. Q4 2022 Earnings Call Transcript
insidermonkey News
over a year ago at finance.yahoo.com         
Icad Reports Q4 Loss, Misses Revenue Estimates
Yahoo News
Far too much social signal, news, headlines, and media speculation about Icad that are available to investors today. That information is available publicly through Icad media outlets and privately through word of mouth or via Icad internal channels. However, regardless of the origin, that massive amount of Icad data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Icad news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Icad relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Icad's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Icad alpha.

Icad Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
iCAD to Report Third Quarter 2024 Financial Results on November 13, 2024
11/05/2024
2
FDA clears AI-powered breast cancer detection tech from iCad
11/12/2024
3
iCAD Reports Financial Results for Third Quarter Ended September 30, 2024
11/13/2024
4
iCAD, Inc. Q3 2024 Earnings Call Transcript
11/15/2024
5
iCAD, Inc. Sees Significant Growth in Short Interest
11/19/2024
6
CORRECTION -- iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI ...
12/04/2024
7
SABCS 2024 New Research Assesses iCADs Image Based AI-Risk, Detection, and Breast Arterial ...
12/11/2024
8
Icad Presents Four AI-Driven Breast Cancer Research Abstracts at the 2024 San Antonio Breast Cancer Symposium
12/12/2024
9
iCAD Stock Crosses Above 200 Day Moving Average Should You Sell
01/03/2025
10
Izotropic Announces Team Leading Clinical Study Design and FDA Regulatory Submissions
01/15/2025

Complementary Tools for Icad Stock analysis

When running Icad's price analysis, check to measure Icad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Icad is operating at the current time. Most of Icad's value examination focuses on studying past and present price action to predict the probability of Icad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Icad's price. Additionally, you may evaluate how the addition of Icad to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
CEOs Directory
Screen CEOs from public companies around the world
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals